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Approximately 170 million people worldwide are thought
to be infected with the hepatitis C virus (HCV).1,2 Studies
from Turkey, with a population of 75 million people, have
shown that 0.3—1.8% of the population is infected with
this pathogen.1—4 HCV is known to be one of the leading
contributors to chronic hepatitis, cirrhosis, hepatocellular
carcinoma, and liver failure throughout the world.5
Parenteral transmission is the primary route of infection,6
and since 1996 the screening of blood products has been
undertaken to prevent transfusion-related transmission in
Turkey.2
Military service is compulsory for all young Turkish men at
the age of 20 years. At the beginning of this service they
congregate randomly from all over the country into the
military training centers. Hence the population in training
centers directly represents the young male population of the
country as a whole. In our study, we assessed the anti-HCV
and HCV-RNA test results of blood donors residing in the
training centers. All HCV-infected cases underwent liver
function tests. The study was divided into two periods,
1998—2000 (first group) and 2001—2005 (second group).
The first group comprised 1938 men and the second group
comprised 15 071. Anti-HCV and HCV-RNA statistical data are
shown in Table 1.Table 1 The distribution of HCV markers in blood donors
Total donors Anti-HCV HCV-RNA
1998—2000 1938 65 (3.35%) 7
2000—2005 15 071 112 (0.74%) 20
Total 177 27
p Values <0.001 0.028Liver function test results were elevated in 26 of 27
(96.3%) HCV-RNA positive patients. Aspartate aminotrans-
ferase (AST) levels were 101  72 IU/L and alanine amino-
transferase (ALT) values were 93  76 IU/L (the cut-off value
was 40).1201-9712/$32.00 # 2006 Published by Elsevier Ltd on behalf of InternIn conclusion, HCV infection seems to be decreasing in the
young male population in Turkey.
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